Cargando…
A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease
BACKGROUND AND OBJECTIVE: HuangZhi YiShen Capsule (HZYS) is a Chinese patent herbal drug that protects kidney function in diabetic kidney disease (DKD) patients. However, the pharmacologic mechanisms of HZYS remain unclear. This study would use network pharmacology to explore the pharmacologic mecha...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386324/ https://www.ncbi.nlm.nih.gov/pubmed/34497749 http://dx.doi.org/10.2478/jtim-2021-0020 |
_version_ | 1783742237903945728 |
---|---|
author | Zhou, Xue-Feng Zhou, Wei-E Liu, Wen-Jing Luo, Min-Jing Wu, Xia-Qing Wang, Ying Liu, Peng Wen, Yu-Min Li, Jia-Lin Zhao, Ting-Ting Zhang, Hao-Jun Zhao, Hai-Ling Li, Ping |
author_facet | Zhou, Xue-Feng Zhou, Wei-E Liu, Wen-Jing Luo, Min-Jing Wu, Xia-Qing Wang, Ying Liu, Peng Wen, Yu-Min Li, Jia-Lin Zhao, Ting-Ting Zhang, Hao-Jun Zhao, Hai-Ling Li, Ping |
author_sort | Zhou, Xue-Feng |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: HuangZhi YiShen Capsule (HZYS) is a Chinese patent herbal drug that protects kidney function in diabetic kidney disease (DKD) patients. However, the pharmacologic mechanisms of HZYS remain unclear. This study would use network pharmacology to explore the pharmacologic mechanisms of HZYS. METHODS: Chemical constituents of HZYS were obtained through the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and literature search. Potential targets of HZYS were identified by using the TCMSP and the SwissTarget Prediction databases. DKD-related target genes were collected by using the Online Mendelian Inheritance in Man, Therapeutic Target Database, GeneCards, DisGeNET, and Drugbank databases. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were carried out to further explore the mechanisms of HZYS in treating DKD. Molecular docking was conducted to verify the potential interactions between the prime compounds and the hub genes. RESULTS: 179 active compounds and 620 target genes were obtained, and 571 common targets were considered potential therapeutic targets. The top 10 main active compounds of HZYS were heparin, quercetin, kaempferol, luteolin, methyl14-methylpentadecanoate, methyl (Z)-11-hexadecenoate, 17-hydroxycorticosterone, 4-pregnene-17α, 20β, 21-triol-3, 11-dione, wogonin, and hydroxyecdysone. Hub signaling pathways by which HZYS treating DKD were PI3K-Akt, MAPK, AGE-RAGE in diabetic complications, TNF, and apoptosis. The top 10 target genes associated with these pathways were IL6, MAPK1, AKT1, RELA, BCL2, JUN, MAPK3, MAP2K1, CASP3, and TNF. Quercetin and Luteolin were verified to have good binding capability with the hub potential targets IL6, MAPK1, AKT1 through molecular docking. CONCLUSION: HZYS appeared to treat DKD by regulating the inflammatory, oxidative stress, apoptotic, and fibrosis signaling pathways. This study provided a novel perspective for further research of HZYS. |
format | Online Article Text |
id | pubmed-8386324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-83863242021-09-07 A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease Zhou, Xue-Feng Zhou, Wei-E Liu, Wen-Jing Luo, Min-Jing Wu, Xia-Qing Wang, Ying Liu, Peng Wen, Yu-Min Li, Jia-Lin Zhao, Ting-Ting Zhang, Hao-Jun Zhao, Hai-Ling Li, Ping J Transl Int Med Original Article BACKGROUND AND OBJECTIVE: HuangZhi YiShen Capsule (HZYS) is a Chinese patent herbal drug that protects kidney function in diabetic kidney disease (DKD) patients. However, the pharmacologic mechanisms of HZYS remain unclear. This study would use network pharmacology to explore the pharmacologic mechanisms of HZYS. METHODS: Chemical constituents of HZYS were obtained through the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and literature search. Potential targets of HZYS were identified by using the TCMSP and the SwissTarget Prediction databases. DKD-related target genes were collected by using the Online Mendelian Inheritance in Man, Therapeutic Target Database, GeneCards, DisGeNET, and Drugbank databases. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were carried out to further explore the mechanisms of HZYS in treating DKD. Molecular docking was conducted to verify the potential interactions between the prime compounds and the hub genes. RESULTS: 179 active compounds and 620 target genes were obtained, and 571 common targets were considered potential therapeutic targets. The top 10 main active compounds of HZYS were heparin, quercetin, kaempferol, luteolin, methyl14-methylpentadecanoate, methyl (Z)-11-hexadecenoate, 17-hydroxycorticosterone, 4-pregnene-17α, 20β, 21-triol-3, 11-dione, wogonin, and hydroxyecdysone. Hub signaling pathways by which HZYS treating DKD were PI3K-Akt, MAPK, AGE-RAGE in diabetic complications, TNF, and apoptosis. The top 10 target genes associated with these pathways were IL6, MAPK1, AKT1, RELA, BCL2, JUN, MAPK3, MAP2K1, CASP3, and TNF. Quercetin and Luteolin were verified to have good binding capability with the hub potential targets IL6, MAPK1, AKT1 through molecular docking. CONCLUSION: HZYS appeared to treat DKD by regulating the inflammatory, oxidative stress, apoptotic, and fibrosis signaling pathways. This study provided a novel perspective for further research of HZYS. Sciendo 2021-06-18 /pmc/articles/PMC8386324/ /pubmed/34497749 http://dx.doi.org/10.2478/jtim-2021-0020 Text en © 2021 Xue-Feng Zhou et al., published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Original Article Zhou, Xue-Feng Zhou, Wei-E Liu, Wen-Jing Luo, Min-Jing Wu, Xia-Qing Wang, Ying Liu, Peng Wen, Yu-Min Li, Jia-Lin Zhao, Ting-Ting Zhang, Hao-Jun Zhao, Hai-Ling Li, Ping A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease |
title | A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease |
title_full | A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease |
title_fullStr | A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease |
title_full_unstemmed | A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease |
title_short | A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease |
title_sort | network pharmacology approach to explore the mechanism of huangzhi yishen capsule for treatment of diabetic kidney disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386324/ https://www.ncbi.nlm.nih.gov/pubmed/34497749 http://dx.doi.org/10.2478/jtim-2021-0020 |
work_keys_str_mv | AT zhouxuefeng anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhouweie anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT liuwenjing anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT luominjing anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT wuxiaqing anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT wangying anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT liupeng anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT wenyumin anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT lijialin anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhaotingting anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhanghaojun anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhaohailing anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT liping anetworkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhouxuefeng networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhouweie networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT liuwenjing networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT luominjing networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT wuxiaqing networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT wangying networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT liupeng networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT wenyumin networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT lijialin networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhaotingting networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhanghaojun networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT zhaohailing networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease AT liping networkpharmacologyapproachtoexplorethemechanismofhuangzhiyishencapsulefortreatmentofdiabetickidneydisease |